For UK private clinics
Most new clinic services fail before they launch, the demand was never there
Private healthcare providers typically invest in staffing, equipment, and marketing before validating whether patients will pay for a new service. The clinical model is rarely the problem. The commercial assumption usually is.
Two minutes. Solva follows up with specific demand validation options.
- Low patient uptake for a newly launched service
- Significant marketing spend yielding poor returns
- Underutilised new equipment or clinical capacity
- Prolonged periods of operating at a loss for the new service
- Underutilised staff and equipment
- Diversion of resources from profitable services
- Significant capital losses from unrecouped investment
- Reduced profitability across the organisation
- Damage to the organisation's reputation for innovation and financial stability
- Loss of trust among investors and potential partners
No verified UK data available
Source: No verified UK data available
Frequently asked questions
Why does this problem persist?
New service launches in private healthcare fail most often because the demand assumption was wrong, not because the clinical model was wrong. Most providers skip the commercial validation step and go straight to building.
What is the cost of leaving it unaddressed?
No verified UK data available
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.